Recruiting
Maternal Mindfulness: Depression and Postpartum Pain
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
ClinicalTrials.gov IDNCT05400382
PhaseNA
Enrollment75
SponsorUniversity of Illinois at Urbana-Champaign
Age18 Years
SexFEMALE
Conditions studied
Depression, Unipolar, Pain, Postoperative
About this study
This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
Interventions
- Behavioral: Mindfulness — Meditation training to help reduce stress and reactivity to pain and other stressors.
Primary outcomes
- Post-operative pain (1 week postpartum and 8 weeks postpartum)
Eligibility information
1. Women must self-identify as Latina/Latinx/Hispanic, Asian, African American, or non-Hispanic White.
2. Scheduled to undergo a planned cesarean delivery.
3. Be of 18-45 years of age
4. Have a singleton pregnancy
5. Score between 5 and 13 on the Edinburgh Postnatal Depression Scale (EPDS)
6. A history of depression
7. Have no chronic pain condition (e.g., fibromyalgia)
8. Own a computer, smartphone, or tablet
9. Have a reliable internet access to complete the online surveys.
10. Be proficient in English or Spanish.
Study locations
- University of Illinois Urbana-Champaign, Champaign, Illinois 61820 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.